Acies bio
Research, development and consulting for the pharmaceutical, food and chemical industries.
| EUR | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 23 % | 38 % | 19 % | 14 % | (3 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 25 % | 9 % | 11 % | 11 % | 10 % | 8 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 10 % | (5 %) | 30 % | 4 % | 1 % | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | - | - | - | - | - | 82 % |
Source: Company filings or news article
Related Content
ACIES BIO is a biotechnology contract research organization offering state-of-the-art R&D services to pharmaceutical, chemical, biotech and food industries. We provide full support from idea conceptualization through research to product development. Combining biotechnology and synthetic organic chemistry expertise, we offer a comprehensive service, covering all key development steps for efficient production of biosynthetic natural products or their semi-synthetic derivatives, as well as entirely synthetic compounds.
Working with some of the largest international companies, we provide to our clients full R&D support both in our laboratories as well as on-site at the client’s facilities.
With experience and know-how in natural product (bio)synthesis, milestone-based approach to projects, innovativeness and flexibility, as well as competitive pricing, ACIES BIO aims to become the premier partner in R&D outsourcing for pharmaceutical companies.